Journal article
In utero Exposure to beta-2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders
Pediatrics (Evanston), v 137(2), pp e20151316-e20151316
01 Feb 2016
PMID: 26738885
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
OBJECTIVES: The purpose of this study was to investigate associations between use of beta-2-adrenergic receptor (B2AR) agonist drugs during pregnancy and risk for autism spectrum disorders (ASD).
METHODS: A case-control study was conducted by using Denmark's health and population registers. Among children born between 1997 and 2006, 5200 cases with ASD admission diagnoses and 52 000 controls without ASD were identified and individually matched on month and year of birth. Conditional logistic regression models were used to estimate odds ratios (OR) and confidence intervals (CI) for any B2AR agonist exposure during pregnancy, preconception, and by trimester.
RESULTS: In total, 3.7% of cases and 2.9% of controls were exposed to B2ARs during pregnancy. Use of B2ARs during pregnancy was associated with increased risk of ASD, even after adjustment for maternal asthma and other covariates (OR: 1.3, 95% CI: 1.1-1.5). The elevated risk was observed with use of B2AR during preconception (OR: 1.3, 95% CI: 1.0-1.6), first trimester (OR: 1.3, 95% CI: 1.1-1.5), second trimester (OR: 1.5, 95% CI: 1.1-1.7), and the third trimester (OR: 1.4, 95% CI: 1.1-1.7). There was some evidence that longer B2AR within-pregnancy use was associated with the increased risk.
CONCLUSIONS: B2AR agonist exposure during pregnancy may be associated with an increased risk for ASD. If the effect is real, any intervention must be balanced against benefits of indicated medication use by pregnant women.
Metrics
Details
- Title
- In utero Exposure to beta-2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders
- Creators
- Nicole B. Gidaya - Drexel UniversityBrian K. Lee - Drexel UniversityIgor Burstyn - Drexel UniversityYvonne Michael - Drexel UniversityCraig J. Newschaffer - Drexel UniversityErik L. Mortensen - Institute of Public Health and Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark
- Publication Details
- Pediatrics (Evanston), v 137(2), pp e20151316-e20151316
- Publisher
- Amer Acad Pediatrics
- Number of pages
- 8
- Grant note
- Drexel University Drexel University Department of Epidemiology and Biostatistics
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Epidemiology and Biostatistics; A.J. Drexel Autism Institute; Environmental and Occupational Health
- Web of Science ID
- WOS:000371392000011
- Scopus ID
- 2-s2.0-84958684831
- Other Identifier
- 991019168620404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Pediatrics